15th Annual Biomarkers Congress

About

Oxford Global is proud to present for the 15th year our flagship Biomarkers Series UK, 18 – 20 February 2020, Manchester, UK. This year promises to be the most exciting Biomarkers Series to date, with a host of new features alongside the popular programme to ensure you gain vital updates on the latest biomarker initiatives and technologies.

With over 100 presentations, the event is designed to provide a comprehensive look at biomarker research from early discovery through to the clinic across multiple therapeutic areas, including oncology, neuroscience, immunology and cardiology. Further sessions focus on topical technological innovation in this space: diagnostic development, imaging, proteomics and immunoassays.

Featuring the following interactive streams:

- Biomarkers in Drug Discovery & Development – Therapeutic Areas: Oncology, Immuno-Oncology and Immunology
- Biomarkers in Drug Discovery & Development – Therapeutic Areas: Neuroscience, Cardiovascular Disorders and Rare Disease
- Biomarkers for Detection, Monitoring & Diagnosis
- New Biomarker Technologies & Data
- Biomarkers for Clinical Development
- Biomarkers for Preclinical Development

New for 2020, we are pleased to announce the following features:

- The Inaugural Genomic Markers Congress: Two dedicated streams on the integration of genomic markers into drug development to enable precision medicine
- A pre-event focus day: Deep-dive sessions in the morning to provide insights into key therapeutic areas from leading experts and end-user workshops in the afternoon to showcase key platforms to incorporate in your workflow. Spaces are limited, so sign-up early to avoid disappointment
- Our Day 1 workshop on Biomarker Qualification: Technical Validation and Regulatory Aspects
- Our Day 2 workshops on Data Analysis and Bioinformatics and Genomic Biobanking to Facilitate Precision Medicine

Price:
Registration starts at: GBP 299.0

Speakers: Miro Venturi, Senior Vice President, Biomarkers, Roche, Roy Baynes, Senior Vice President, Chief Medical Officer, MSD, Alastair Lawson, Fellow and Vice President, Structural Biology, UCB, Holly Soares, Head of Precision Medicine, Vice President, Pfizer, Mark Fidock, Vice President, AstraZeneca